Cardiomyopathy induced by cardiac G(S)α overexpression

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 1 41-1, 1997, Pages

  Iwase, Mitsunori ^a   Uechi, Masami ^a   Vatner, Dorothy E ^a,b   Asai, Kuniya ^a   Shannon, Richard P ^a,b,c   Kudej, Raymond K ^a   Wagner, Thomas E ^d   Wight, David C ^d   Patrick, Thomas A ^a   Ishikawa, Yoshihiro ^a,b   Homcy, Charles J ^e   Vatner, Stephen F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d OHIO UNIVERSITY   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

echocardiography; guanosine 5' triphosphate stimulatory G protein subunit; heart failure; sympathetic drive; transgenic mice

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; ELECTROCARDIOGRAM; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RHYTHM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TRANSGENIC MOUSE;

EID: 20644467055     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.1.h585     Document Type: Article

References (25)

1. Bristow, M. R., R. Ginsberg, M. Minobe, R. S. Cubiciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. C. Harrison, and E. B. Stinson. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307: 205-211, 1982.
2. Cintron, G., G. Johnson, G. Francis, F. Cobb, and J. N. Cohn. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 87, Suppl. VI: VI-17-VI-23, 1993.
3. Cohn, J. N., and T. S. Rector. Prognosis of congestive heart failure and predictors of mortality. Am. J. Cardiol. 62: 25A-30A, 1988.
4. Colucci, W. S., R. F. Wright, and E. Braunwald. New positive inotropic agents in the treatment of congestive heart failure (part one). N. Engl. J. Med. 314: 290-299, 1986.
5. Colucci, W. S., R. F. Wright, and E. Braunwald. New positive inotropic agents in the treatment of congestive heart failure (part two). N. Engl. J. Med. 314: 349-358, 1986.
6. Francis, G. S., C. Benedict, D. E. Johnstone, P. C. Kirlin, J. Nicklas, C.-S. Liang, S. H. Kubo, E. Rudin-Toretsky, and S. Yusuf. Comparison of neuroendocrine activation in patients with left ventricualr dysfunction with and without congestive heart failure. Circulation 82: 1724-1729, 1990.
7. sα protein in the hearts of transgenic mice. J. Clin. Invest. 95: 1676-1686, 1995.
8. Gilbert, E. M., J. L. Anderson, D. Deitchman, F. G. Yanowitz, J. B. O'Connell, D. G. Renlund, M. Bartholomew, P. C. Mealey, P. Larrabee, and M. R. Bristow. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind randomized study of bucindolol versus placebo. Am. J. Med. 88: 223-229, 1990.
9. Heilbrunn, S. M., P. Shah, M. R. Bristow, H.A. Valantine, R. Ginsburg, and M. B. Fowler. Increased β-adrenergic receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79: 483-490, 1989.
10. Hoit, B. D., S. F. Khoury, E. G. Kranias, N. Ball, and R. A. Walsh. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77: 632-637, 1995.
11. sα overexpression. Circ. Res. 78: 517-524, 1996.
12. Kiuchi, K., R. P. Shannon, K. Komamura, D. J. Cohen, C. Bianchi, C. J. Homey, S. F. Vatner, and D. E. Vatner. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J. Clin. Invest. 91: 907-914, 1993.
13. Koch, W. J., C. J. Milano, and R. J. Lefkowitz. Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinase. Circ. Res. 78: 511-516, 1996.
14. Koch, W. J., H. A. Rockman, P. Samama, R. Hamilton, R. A. Bond, C. A. Milano, and R. J. Lefkowitz. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or βARK inhibitor. Science Wash. DC 268: 1350-1353, 1995.
15. Krell, M. J., E. M. Kline, E. R. Bates, J. M. B. Hodgeson, L. R. Dilworth, N. Laufer, R. A. Vogel, and B. Pitt. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am. Heart J. 112: 787-791, 1986.
16. Lambertz, H., J. Meyer, and R. Erbel. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation 69: 298-305, 1984.
17. Metra, M., M. Nardi, R. Giubbini, and L. D. Cas. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 24: 1678-1687, 1994.
18. 2-adrenergic receptor. Science Wash. DC 264: 582-586, 1994.
19. Olsen, S. L., E. M. Gilbert, D. G. Renlund, D. O. Taylor, F. D. Yanowitz, and M. R. Bristow. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a doubleblind randomized study. J. Am. Coll. Cardiol. 25: 1225-1231, 1995.
20. Packer, M., J. R. Carver, R. J. Rodeheffer, R. J. Ivanhoe, R. DiBianco, S. M. Zeildis, G. H. Heyndrickx, W. J. Bommer, U. Elkayam, M. L. Kukin, G. I. Mallis, R. N. Sollano, J. Shannon, P. K. Tandon, and D. L. DeMets. PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N. Engl. J. Med. 325: 1468-1475, 1991.
21. Sahn, D. J., A. DeMaria, J. Kisslo, and A. Weyman. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
22. Strein, K., G. Sponer, B. Müller-Beckmann, and W. Bartsch. Pharmacological profile of carvedilol, a compound with β-blocking and vasodilating properties. J. Cardiovasc. Pharmacol. 10: S33-S41, 1987.
23. Vatner, D. E., N. Sato, K. Kiuchi, R. P. Shannon, and S. F. Vatner. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation 90: 1423-1430, 1994.
24. Waagstein, F., I. Caidahl, I. Wallentin, C.-H. Bergh, and A. Hjalmarson. Long-term β-blockade in dilated cardiomyopathy. Circulation 80: 551-563, 1989.
25. Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. Lancet 336: 1-6, 1990.